Cargando…

EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2

Due to the challenges for developing vaccines in devastating pandemic situations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), developing and screening of novel antiviral agents are peremptorily demanded. Herein, we developed EGYVIR as a potent immunomodulatory herbal extract with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roshdy, Wael H., Rashed, Helmy A., Kandeil, Ahmed, Mostafa, Ahmed, Moatasim, Yassmin, Kutkat, Omnia, Abo Shama, Noura M., Gomaa, Mokhtar R., El-Sayed, Ibrahim H., El Guindy, Nancy M., Naguib, Amal, Kayali, Ghazi, Ali, Mohamed A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673558/ https://www.ncbi.nlm.nih.gov/pubmed/33206688 http://dx.doi.org/10.1371/journal.pone.0241739

Ejemplares similares

Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies
por: Kutkat, Omnia, et al.
Publicado: (2022)

Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Egypt
por: Kandeil, Ahmed, et al.
Publicado: (2020)

Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in Egyptian Convalescent Plasma Donors
por: Gomaa, Mokhtar R., et al.
Publicado: (2020)

Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2
por: Kandeil, Ahmed, et al.
Publicado: (2020)

Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E
por: Moatasim, Yassmin, et al.
Publicado: (2023)

Impact of Individual Viral Gene Segments from Influenza A/H5N8 Virus on the Protective Efficacy of Inactivated Subtype-Specific Influenza Vaccine
por: Moatasim, Yassmin, et al.
Publicado: (2021)

Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort
por: Gomaa, Mokhtar R., et al.
Publicado: (2021)

Bioactive Polyphenolic Compounds Showing Strong Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus 2
por: Kandeil, Ahmed, et al.
Publicado: (2021)

Whole-Genome Sequence of a Human Monkeypox Virus Strain Detected in Egypt
por: Roshdy, Wael H., et al.
Publicado: (2023)

Comparative pathogenic potential of avian influenza H7N3 viruses isolated from wild birds in Egypt and their sensitivity to commercial antiviral drugs
por: Kayed, Ahmed E., et al.
Publicado: (2023)

Induced humoral immunity of different types of vaccines against most common variants of SARS-CoV-2 in Egypt prior to Omicron outbreak
por: El-Shesheny, Rabeh, et al.
Publicado: (2022)

We are underestimating, again, the true burden of H5N1 in humans
por: Gomaa, Mokhtar, et al.
Publicado: (2023)

Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt
por: Ali, Mohamed A, et al.
Publicado: (2017)

Insights into Genetic Characteristics and Virological Features of Endemic Avian Influenza A (H9N2) Viruses in Egypt from 2017–2021
por: El Sayes, Mohamed, et al.
Publicado: (2022)

Incidence and seroprevalence of seasonal influenza a viruses in Egypt: Results of a community‐based cohort study
por: Gomaa, Mokhtar R., et al.
Publicado: (2022)

Active surveillance and genetic evolution of avian influenza viruses in Egypt, 2016–2018
por: Kandeil, Ahmed, et al.
Publicado: (2019)

FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2
por: Mostafa, Ahmed, et al.
Publicado: (2020)

Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020–2022: insight into SARS-Cov-2 genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortality
por: Kandeel, Amr, et al.
Publicado: (2023)

Comparative Virological and Pathogenic Characteristics of Avian Influenza H5N8 Viruses Detected in Wild Birds and Domestic Poultry in Egypt during the Winter of 2016/2017
por: Moatasim, Yassmin, et al.
Publicado: (2019)

Delineating a potent antiviral activity of Cuphea ignea extract loaded nano-formulation against SARS-CoV-2: In silico and in vitro studies
por: Mahmoud, Dina B., et al.
Publicado: (2021)

In Vitro and In Vivo Antiviral Studies of New Heteroannulated 1,2,3-Triazole Glycosides Targeting the Neuraminidase of Influenza A Viruses
por: Kutkat, Omnia, et al.
Publicado: (2022)

Active Surveillance for Avian Influenza Virus, Egypt, 2010–2012
por: Kayali, Ghazi, et al.
Publicado: (2014)

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies
por: Kandeil, Ahmed, et al.
Publicado: (2021)

Highly Pathogenic Avian Influenza A(H5N1) Virus Clade 2.3.4.4b in Wild Birds and Live Bird Markets, Egypt
por: El-Shesheny, Rabeh, et al.
Publicado: (2022)

Middle East respiratory syndrome coronavirus infection in non-camelid domestic mammals
por: Kandeil, Ahmed, et al.
Publicado: (2019)

Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt
por: El Rifay, Amira S., et al.
Publicado: (2021)

Complete Genome Sequence of Middle East Respiratory Syndrome Coronavirus Isolated from a Dromedary Camel in Egypt
por: Kandeil, Ahmed, et al.
Publicado: (2016)

Genetic and Antigenic Characteristics of Highly Pathogenic Avian Influenza A(H5N8) Viruses Circulating in Domestic Poultry in Egypt, 2017–2021
por: Kandeil, Ahmed, et al.
Publicado: (2022)

Incidence and Seroprevalence of Avian Influenza in a Cohort of Backyard Poultry Growers, Egypt, August 2015–March 2019
por: Gomaa, Mokhtar R., et al.
Publicado: (2020)

A Recombinant Influenza A/H1N1 Carrying A Short Immunogenic Peptide of MERS-CoV as Bivalent Vaccine in BALB/c Mice
por: Shehata, Mahmoud M., et al.
Publicado: (2019)

3-Alkenyl-2-oxindoles: Synthesis, antiproliferative and antiviral properties against SARS-CoV-2
por: Girgis, Adel S., et al.
Publicado: (2021)

Incidence and neutralizing antibody seroprevalence of influenza B virus in Egypt: Results of a community-based cohort study
por: Abo Shama, Noura M., et al.
Publicado: (2022)

Insight into Genetic Characteristics of Identified SARS-CoV-2 Variants in Egypt from March 2020 to May 2021
por: Roshdy, Wael H., et al.
Publicado: (2022)

Diversity of Astroviruses Circulating in Humans, Bats, and Wild Birds in Egypt
por: El Taweel, Ahmed, et al.
Publicado: (2020)

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East
por: Kandeil, Ahmed, et al.
Publicado: (2019)

Surveillance for avian influenza viruses in wild birds at live bird markets, Egypt, 2014‐2016
por: Kayed, Ahmed S., et al.
Publicado: (2019)

Design, Synthesis and In Vitro Evaluation of Spirooxindole-Based Phenylsulfonyl Moiety as a Candidate Anti-SAR-CoV-2 and MERS-CoV-2 with the Implementation of Combination Studies
por: Barakat, Assem, et al.
Publicado: (2022)

Investigating the Potential Anti-SARS-CoV-2 and Anti-MERS-CoV Activities of Yellow Necklacepod among Three Selected Medicinal Plants: Extraction, Isolation, Identification, In Vitro, Modes of Action, and Molecular Docking Studies
por: Abd-Alla, Howaida I., et al.
Publicado: (2022)

Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N-(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro and in silico studies
por: Al-Karmalawy, Ahmed A., et al.
Publicado: (2023)

Development of spiro-3-indolin-2-one containing compounds of antiproliferative and anti-SARS-CoV-2 properties
por: Fawazy, Nehmedo G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rblkmh9j73hbf5fh6sppc4hv6r